• careers
  • sitemap
  • contact

AdvaxisAdvaxis - Technology in Immunoterapy

  • Company
    • Overview
    • Management
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Why Listeria
    • How Advaxis Uses Listeria
    • Common Concerns
    • Intellectual Property
    • Bibliography
    • Vaccine Congress Presentation
  • Clinical Development
    • Lovaxin C
    • Lovaxin B
    • Lovaxin P
    • Lovaxin SCCE
  • Investors
    • Overview
    • Fact Sheet
    • Company PowerPoint
    • Webcasts
  • News
    • 2008 Press releases
    • 2007 Press releases
    • 2006 Press releases
    • 2005 Press releases
    • 2004 Press releases
    • 2003 Press releases
    • 2002 Press releases

Archives

  • 2008 Press Releases
  • 2007 Press Releases
  • 2006 Press Releases
  • 2005 Press Releases
  • 2004 Press Releases
  • 2003 Press Releases
  • 2002 Press Releases

News

2008 Press Releases

May 20, 2008
Advaxis Files Investigational New Drug Application with U.S. Food and Drug Administration

May 2, 2008
Advaxis Receives Research Coverage

April 29, 2008
Advaxis Taps Former ''Big Pharma'' FDA Specialist

April 18, 2008
Advaxis' Listeria Monocytogenes-Based Vaccine Garners National Media Attention

April 17, 2008
Advaxis to Collaborate with City of Hope, a Leading Cancer Research and Treatment Center

April 15, 2008
Advaxis Discloses Clinical Results of the First Ever Live Listeria Monocytogenes Trial

April 3, 2008
Advaxis Inc. to Present at the LD Micro Growth Conference in Los Angeles, CA

March 31, 2008
Advaxis' Cancer Platform Featured in New Scientist

March 4, 2008
Advaxis Scientists Publish Research of Listeria Monocytogenes-Based Vaccine for Prostate Cancer in Latest Edition of Cancer Immunology & Immunotherapy

February 18, 2008
A Shot in the Arm Against Early Stage Cervical Cancer

January 23, 2008
Advaxis to Host Dinner Reception For Members of the Gynecologic Oncology Group (GOG)

Home

Copyright © 2008 - Advaxis Inc. - All rights reserved